Skip to main content
Log in

Growth hormone status in morbidly obese subjects and correlation with body composition

  • Original Articles
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Morbidly obese subjects are characterized by multiple endocrine abnormalities and these are paralleled by unfavorable changes in body composition. In obese individuals, either 24-h spontaneous or stimulated GH secretion is impaired without an organic pituitary disease and the severity of the secretory defect is proportional to the degree of obesity. The GHRH+arginine (GHRH+ARG) test is likely to be the overall test of choice in clinical practice to differentiate GH deficiency (GHD) patients. Similarly to other provocative tests, GHRH+ARG is influenced by obesity per se. Therefore, a new cut-off limit of peak GH response of 4.2 µg/l in obese subjects has been recently assumed. The aim of the present study was to investigate the reciprocal influence between decreased GH secretion and body composition in a group of 110 morbidly obese subjects, using the new cut-off limit of peak GH response to GHRH+ARG test for these subjects. In our study, GHD was identified in 27.3% of the obese subjects, without gender difference. In GDH obese subjects body mass index (BMI), waist circumference, waist-to-hip ratio (WHR), fat mass (FM), and resistance (R) were higher while reactance (Xc), phase angle, body cell mass (BCM), IGF-I, or IGF-I z-scores were lower than in normal responders (p<0.001). In all obese subjects, GH peak levels showed a negative correlation with age, BMI, waist circumference and FM, and a positive correlation with IGF-I. In the stepwise multiple linear regression, waist circumference and FM were the major determinants of GH peak levels and IGF-I. In conclusion, using the new cut-off limit of peak GH response to GHRH+ARG test for obese subjects, about 1/3 morbidly obese subjects were GHD. GHD subjects showed a significantly different body composition compared with normal responders, and the secretory defect was correlated to different anthropometric variables with waist circumference and FM as the major determinants.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Kopelman PG. Hormones and obesity. Baillieres Clin Endocrinol Metab 1994, 8: 549–75.

    Article  CAS  PubMed  Google Scholar 

  2. Pasquali R, Vicennati V, Gambineri A, Pagotto U. Hormones and pathophysiology of obesity. Eat Weight Disord 2001, 6(3 Suppl): 9–20.

    CAS  PubMed  Google Scholar 

  3. Aronne LJ, Segal KR. Adiposity and fat distribution outcome measures: assessment and clinical implications. Obes Res 2002, 10(Suppl 1): 14S–21S.

    Article  PubMed  Google Scholar 

  4. Scacchi M, Pincelli AI, Cavagnini F. Growth hormone in obesity. Int J Obesity 1999, 23: 262–71.

    Google Scholar 

  5. Giustina A, Veldhuis JD. Pathophysiology of the neuroregulation of growth hormones secretion in experimental animals and the human. Endocr Rev 1998, 19: 717–97.

    CAS  PubMed  Google Scholar 

  6. Franco C, Bengtsson BA, Johannsson G. Visceral obesity and the role of the somatotropic axis in the development of metabolic complications. Growth Horm IGF Res 2001, 11(Suppl A): S97–102.

    Article  PubMed  Google Scholar 

  7. Maccario M, Tassone F, Grottoli S, Rossetto R, Gauna C, Ghigo E. Neuroendocrine and metabolic determinants of the adaptation of GH/IGF-I axis to obesity. Ann Endocrinol (Paris) 2002, 63: 140–4.

    CAS  Google Scholar 

  8. Qu XD, Gonzalo TGI, Al Sayed MY, et al. Influence of body mass index and gender on GH responses to GHRH plus Arginine and Insulin tolerance test. J Clin Endocrinol Metab 2005, 90: 1563–9.

    Article  CAS  PubMed  Google Scholar 

  9. Veldhuis JD, Iranmanesh A, Ho KK, Waters MJ, Johnson ML, Lizarralde G. Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man. J Clin Endocrinol Metab 1991, 72: 51–9.

    Article  CAS  PubMed  Google Scholar 

  10. Colao A, Di Somma C, Pivonello R, et al. Bone loss is correlated to the severity of growth hormone (GH) deficiency in adult patients with hypopituitarism. J Clin Endocrinol Metab 1999, 84: 1919–24.

    CAS  PubMed  Google Scholar 

  11. Colao A, Cerbone G, Pivonello R, et al. The growth hormone (GH) response to arginine plus GH releasing hormone test is correlated to the severity of lipid profile abnormalities in adult patients with GH deficiency. J Clin Endocrinol Metab 1999, 84: 1277–82.

    Article  CAS  PubMed  Google Scholar 

  12. Colao A, Di Somma C, Cuocolo A, et al. The severity of growth hormone deficiency correlates with the severity of cardiac impairment in 100 adult patients with hypopituitarism: an observational, case-control study. J Clin Endocrinol Metab 2004, 89: 5998–6004.

    Article  CAS  PubMed  Google Scholar 

  13. Murray RD, Adams JE, Shalet SM. Adults with partial growth hormone deficiency have an adverse body composition. J Clin Endocrinol Metab 2004, 89: 1586–91.

    Article  CAS  PubMed  Google Scholar 

  14. Ghigo E, Aimaretti G, Gianotti L, Bellone J, Arvat E, Camanni F. New approach to the diagnosis of growth hormone deficiency in adults. Eur J Endocrinol 1996, 134: 352–6.

    Article  CAS  PubMed  Google Scholar 

  15. Biller BM, Samuels MH, Zagar A, et al. Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency. J Clin Endocrinol Metab 2002, 87: 2067–79.

    Article  CAS  PubMed  Google Scholar 

  16. Corneli G, Di Somma C, Baldelli R, et al. The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index. Eur J Endocrinol 2005, 153: 257–64.

    Article  CAS  PubMed  Google Scholar 

  17. Hu FB, Rimm E, Smith-Warner SA, et al. Reproducibility and validity of dietary patterns assessed with a food-frequency questionnaire. Am J Clin Nutr 1999, 69: 243–9.

    CAS  PubMed  Google Scholar 

  18. Kushner RF. Bioelectrical impedance analysis: A rewiew of principles and applications. J Am Coll Nutr 1992, 11: 199–209.

    CAS  PubMed  Google Scholar 

  19. Kotler DP, Burastero S, Wang J, et al. Prediction of body cell mass, fat-free mass, and total body water with bioelectrical impedance analysis: effect of race, sex, and disease. Am J Clin Nutr 1996, 64: 489S-97S.

    Google Scholar 

  20. Piccoli A, Rossi B, Pillon L, Bucciante G. A new method for monitoring body fluid variation by bioimpedance analysis: The RXc graph. Kidney Int 1994, 46: 534–9.

    Article  CAS  PubMed  Google Scholar 

  21. Piccoli A, Brunani A, Savia G, et al. Discriminating between body fat and fluid changes in the obese adult using bioimpedance vector analysis. Int J Obes 1998, 22: 97–104.

    Article  CAS  Google Scholar 

  22. Savastano S, Belfiore A, Guida B, et al. A Role of dehydroe-piandrosterone-sulphate levels on body composition after laparoscopic adjustable gastric banding in premenopausal morbidly obese women. J Endocrin Invest 2005, 28: 509–15.

    Article  CAS  Google Scholar 

  23. Growth Hormone Research Society Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency. J Clin Endocrinol Metab 1998, 83: 379–81.

    Google Scholar 

  24. Fisker S, Jorgensen JO, Christiansen JS. Variability in growth hormone stimulation tests. Growth Horm IGF Res 1998, 8(Suppl A): 31–5.

    Article  CAS  PubMed  Google Scholar 

  25. Aimaretti G, Corneli G, Razzore P, et al. Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone+arginine as provocative tests for the diagnosis of GH deficiency in adults. J Clin Endocrinol Metab 1998, 83: 1615–8.

    CAS  PubMed  Google Scholar 

  26. Aimaretti G, Baffoni C, Di Vito L, et al. Comparisons among old and new provocative tests of GH secretion in 178 normal adults. Eur J Endocrinol 2000, 142: 347–52.

    Article  CAS  PubMed  Google Scholar 

  27. Imaki T, Shibasaki T, Shizume K, et al. The effect of free fatty acids on growth hormone (GH)-releasing hormone-mediated GH secretion in man. J Clin Endocrinol Metab 1985, 60: 290–3.

    Article  CAS  PubMed  Google Scholar 

  28. Casanueva FF, Villanueva L, Dieguez, et al. A free fatty acids block growth hormone (GH) releasing hormone-stimulated GH secretion in man directly at he pituitary. J Clin Endocrinol Metab 1987, 65: 634–42.

    Article  CAS  PubMed  Google Scholar 

  29. Maccario M, Procopio M, Loche S, et al. Interaction of free fatty acids and arginine on growth hormone secretion in man. Metabolism 1994, 43: 223–6.

    Article  CAS  PubMed  Google Scholar 

  30. Iranmanesh A, Lizarralde G, Veldhuis JD. Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. J Clin Endocrinol Metab 1991, 73: 1081–8.

    Article  CAS  PubMed  Google Scholar 

  31. Busetto L, Baggio MB, Zurlo F, Carraro R, Digito M, Enzi G. Assessment of abdominal fat distribution in obese patients: anthropometry versus computerized tomography. Int J Obes Relat Metab Disord 1992, 16: 731–6.

    CAS  PubMed  Google Scholar 

  32. Maccario M, Ramunni J, Oleandri SE, et al. Relationships between IGF-I and age, gender, body mass, fat distribution, metabolic and hormonal variables in obese patients. Int J Obes 1999, 23: 612–8.

    Article  CAS  Google Scholar 

  33. Santini F, Pinchera A, Marsili A, et al. Lean body mass is a major determinant of levothyroxine dosage in ht e treatment of thyroid diseases J Clin Endocrinol Metab 2005, 90: 124–7.

    Article  CAS  PubMed  Google Scholar 

  34. Veldhuis JD. Gender differences in secretory activity of the human somatotropic (growth hormone) axis. Eur J Endocrinol 1996, 134: 287–95.

    Article  CAS  PubMed  Google Scholar 

  35. van den Berg G, Veldhuis JD, Frolich M, Roelfsema F. An amplitude-specific divergence in the pulsatile mode of growth hormone (GH) secretion underlies the gender difference in mean GH concentrations in men and premenopausal women. J Clin Endocrinol Metab 1996, 81: 2460–7.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S. Savastano MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Savastano, S., Di Somma, C., Belfiore, A. et al. Growth hormone status in morbidly obese subjects and correlation with body composition. J Endocrinol Invest 29, 536–543 (2006). https://doi.org/10.1007/BF03344144

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03344144

Key-words

Navigation